Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
BioPartners
BioPartners
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ribavirin biopartners
Ribavirin
2010-04-06
Chronic hepatitis c
,
Human adenovirus infections
,
Respiratory syncytial virus infections
,
Virus diseases
,
West nile fever
Somatropin biopartners
Somatropin
2013-08-05
Growth
,
Pituitary dwarfism
,
Prader-willi syndrome
,
Turner syndrome
,
Cachexia
,
Dwarfism
,
Heart failure
,
Noonan syndrome
Valtropin
Somatropin
2006-04-24
Growth
,
Pituitary dwarfism
,
Prader-willi syndrome
,
Turner syndrome
,
Cachexia
,
Dwarfism
,
Heart failure
,
Noonan syndrome
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Somatropin
laron syndrome
,
pituitary diseases
Somatropin pegol
laron syndrome
,
pituitary diseases
Interferon beta
relapsing-remitting multiple sclerosis
Albumin
relapsing-remitting multiple sclerosis
Etrolizumab
relapsing-remitting multiple sclerosis
Sodium chloride
relapsing-remitting multiple sclerosis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use